The Use of a Novel Heart Failure Agent in the Treatment of Pregnancy-Associated Cardiomyopathy
Peripartum cardiomyopathy is an uncommon, pregnancy-related form of dilated cardiomyopathy that is associated with development of new-onset left ventricular dysfunction. Its etiology is presently unknown, but current standard of care involves the use of typical drug therapy for the treatment of hear...
Main Authors: | Vamsi C. Gaddipati, Aarti A. Patel, Adam J. Cohen |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | Case Reports in Cardiology |
Online Access: | http://dx.doi.org/10.1155/2017/9561405 |
Similar Items
-
Pregnancy-Associated Heart Failure: A Comparison of Clinical Presentation and Outcome between Hypertensive Heart Failure of Pregnancy and Idiopathic Peripartum Cardiomyopathy.
by: Ntobeko B A Ntusi, et al.
Published: (2015-01-01) -
Pathogenesis and treatment of heart failure in dilated cardiomyopathy
by: M. A. Gurevich
Published: (2005-02-01) -
SPIRAPRIL IN TREATMENT OF HEART FAILURE DUE TO DILATED CARDIOMYOPATHY
by: T. A. Abdullaev, et al.
Published: (2002-02-01) -
Chagas cardiomyopathy and heart failure: From epidemiology to treatment
by: Érico Santos, et al.
Published: (2020-05-01) -
Chagas cardiomyopathy and heart failure: From epidemiology to treatment
by: Érico Santos, et al.
Published: (2020-05-01)